These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6450001)

  • 1. Circulating platelet products in unstable angina pectoris.
    Sobel M; Salzman EW; Davies GC; Handin RI; Sweeney J; Ploetz J; Kurland G
    Circulation; 1981 Feb; 63(2):300-6. PubMed ID: 6450001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
    Théroux P; Latour JG; Léger-Gauthier C; De Lara J
    Circulation; 1987 Jan; 75(1):156-62. PubMed ID: 2947740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
    van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
    Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome.
    Grande P; Grauholt AM; Madsen JK
    Circulation; 1990 Jan; 81(1 Suppl):I16-9; discussion I22-3. PubMed ID: 2136815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina.
    Zahavi M; Zahavi J; Schafer R; Firsteter E; Laniado S
    Thromb Haemost; 1989 Nov; 62(3):840-5. PubMed ID: 2531938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
    Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
    Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Newly developed stenocardia: functional activity of thrombocytes].
    Shalaev SV; Panchenko EP; Masenko VP; Smirnov IE; Vinogradova IV
    Kardiologiia; 1988 Jul; 28(7):63-8. PubMed ID: 2974904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease.
    Tahara A; Yasuda M; Itagane H; Toda I; Teragaki M; Akioka K; Oku H; Takeuchi K; Takeda T; Bannai S
    Am Heart J; 1991 Oct; 122(4 Pt 1):986-92. PubMed ID: 1833965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
    Gallino A; Haeberli A; Baur HR; Straub PW
    Circulation; 1985 Jul; 72(1):27-30. PubMed ID: 2408785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood.
    Marcella JJ; Nichols AB; Johnson LL; Owen J; Reison DS; Kaplan KL; Cannon PJ
    J Am Coll Cardiol; 1983 May; 1(5):1185-93. PubMed ID: 6339591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unstable stenocardia: indicators of platelet activity and the effect of verapamil].
    Gratsianskiĭ NA; Chikvashvili DI; Masenko VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):33-9. PubMed ID: 2962587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
    Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
    Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocyte aggregation, levels of thrombocyte factor 4 and beta-thromboglobulin in the blood plasma of patients with unstable stenocardia and acute myocardial infarct].
    Arkad'eva GE; Blagosklonnyĭ MV
    Kardiologiia; 1988 May; 28(5):99-101. PubMed ID: 2970561
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.
    Montalescot G; Drobinski G; Maclouf J; Maillet F; Salloum J; Ankri A; Kazatchkine M; Eugène L; Thomas D; Grosgogeat Y
    Circulation; 1991 Nov; 84(5):2054-62. PubMed ID: 1934381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4.
    De Caterina R; Gazzetti P; Mazzone A; Marzilli M; L'Abbate A
    Eur Heart J; 1988 Aug; 9(8):913-22. PubMed ID: 2972544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein(a) and hemostasis activation markers in angina pectoris].
    Tsakiris DA; Riesen WF; Marbet GA
    Dtsch Med Wochenschr; 1995 Aug; 120(33):1109-13. PubMed ID: 7656834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
    Hirsh PD; Firth BG; Campbell WB; Dehmer GJ; Willerson JT; Hillis LD
    Am J Cardiol; 1983 Mar; 51(5):727-33. PubMed ID: 6829431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.